Matches in Wikidata for { <http://www.wikidata.org/entity/Q66042575> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66042575 description "clinical trial" @default.
- Q66042575 description "ensayu clínicu" @default.
- Q66042575 description "klinisch onderzoek" @default.
- Q66042575 description "клінічне випробування" @default.
- Q66042575 name "Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins" @default.
- Q66042575 name "Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins" @default.
- Q66042575 type Item @default.
- Q66042575 label "Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins" @default.
- Q66042575 label "Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins" @default.
- Q66042575 prefLabel "Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins" @default.
- Q66042575 prefLabel "Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins" @default.
- Q66042575 P1050 Q66042575-1AC9B95E-3DE3-4EBC-8271-6219C46DA297 @default.
- Q66042575 P1132 Q66042575-0C861623-EE72-4DD4-AB84-7E1A326B70E4 @default.
- Q66042575 P1476 Q66042575-361A925E-C547-463C-9D78-C6BB5534A625 @default.
- Q66042575 P17 Q66042575-5233B337-DD33-4601-AA45-2A512EF55360 @default.
- Q66042575 P1813 Q66042575-B95A7C17-C2B2-4D5D-8FFF-B2AF277825ED @default.
- Q66042575 P2899 Q66042575-0E054132-6F8F-44CB-B930-11A147788771 @default.
- Q66042575 P3098 Q66042575-C23AA50D-831E-4127-A9A3-5A7527A303C7 @default.
- Q66042575 P31 Q66042575-422D69A4-ACB5-4038-BBDF-00AF3120B849 @default.
- Q66042575 P580 Q66042575-5D82696B-EC06-4C83-9302-87A26D52A6D0 @default.
- Q66042575 P582 Q66042575-B0668090-CA2B-40E5-A51F-EC84830EFAAF @default.
- Q66042575 P6099 Q66042575-7068056B-1891-4223-9ADC-77D256FCFEB7 @default.
- Q66042575 P6153 Q66042575-21591B9A-78CF-4883-BC40-AFE910424A15 @default.
- Q66042575 P8363 Q66042575-6DE2E295-CD0C-4BBF-A149-D23B85AB504F @default.
- Q66042575 P1050 Q332428 @default.
- Q66042575 P1132 "+256" @default.
- Q66042575 P1476 "A Phase 2, Open-Label, Dose-Titrating Safety and Efficacy Study of QGC001 Administered Orally, Twice Daily, Over 8 Weeks in Hypertensive Overweight Subjects of Multiple Ethnic and Racial Groups in the United States" @default.
- Q66042575 P17 Q30 @default.
- Q66042575 P1813 "NEW-HOPE" @default.
- Q66042575 P2899 "+18" @default.
- Q66042575 P3098 "NCT03198793" @default.
- Q66042575 P31 Q30612 @default.
- Q66042575 P580 "2017-10-13T00:00:00Z" @default.
- Q66042575 P582 "2018-10-16T00:00:00Z" @default.
- Q66042575 P6099 Q42824440 @default.
- Q66042575 P6153 Q30270351 @default.
- Q66042575 P8363 Q78089383 @default.